Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH- Gastric Cancer

Currently, effective therapies for advanced gastric cancer with systemic metastasis are lacking. Pharmacological research has been slowly progressing over the past decades. Here, we report the case of a 56-year-old female with human epidermal growth factor receptor 2 (HER2) expression (IHC 2+/FISH-)...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Li, Jin, Xiangren, Wang, Liuxing, Wang, Haibin, Yan, Zhiqiang, Wang, Guanghai, Liang, Baichuang, Huang, Fu, Luo, Yuling, Chen, Taichun, Wang, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935729/
https://www.ncbi.nlm.nih.gov/pubmed/35321517
http://dx.doi.org/10.2147/OTT.S349096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935729/
https://www.ncbi.nlm.nih.gov/pubmed/35321517
http://dx.doi.org/10.2147/OTT.S349096

Ejemplares similares